News
Microarray technology is now widely available and is being applied to address increasingly complex scientific questions. Consequently, there is a greater demand for statistical assessment of the ...
The detection of autoantibodies to tumor antigens has potential utility for the early diagnosis of cancers. In previous studies, we have identified tumor antigens based on Western blot analysis of ...
Maybe one of these days FIFA’s actions will back up its big talk about combatting hate and discrimination. Today is not that day, however. A month after FIFA president Gianni Infantino said ...
Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via “patch” technology and utilizes Micron’s first-in-class dissolvable microarray technology Research builds on ...
Research builds on Emory’s research on influenza vaccines self-administered via Micron’s microarray technology. This trial represents first-ever CDC-sponsored clinical trial of vaccine ...
Targeting to address one of the grandest challenges in HfO$_ {2} -$based ferroelectric (FE) materials and devices, we invent a novel, effective, and versatile te ...
Cancer is the second leading cause of death globally. According to the World Health Organization (WHO) in 2018, approximately 9.6 million deaths were caused by cancer. Globally, about 1 in 6 deaths ...
Aspects of the research and practice paradigm known as the diffusion of innovations are applicable to the complex context of health care, for both explanatory and interventionist purposes. This ...
Antibody microarrays can detect multiple proteins simultaneously, but the need for bulky and expensive fluorescence scanners limits their adaptation in clinical settings. Here we introduce a 15-plex ...
There are a variety of options for making microarrays and obtaining microarray data. Here, we describe the building and use of two microarray facilities in academic settings. In addition to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results